-
1
-
-
73149102059
-
-
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, MMWR Surveill Summ
-
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, MMWR Surveill Summ 2009; 58:1-20.
-
(2009)
, vol.58
, pp. 1-20
-
-
-
2
-
-
69249164140
-
Syndromic autism: causes and pathogenetic pathways
-
Benvenuto A., Moavero R., Alessandrelli R., Manzi B., Curatolo P. Syndromic autism: causes and pathogenetic pathways. World J Pediatr 2009, 5:169-176.
-
(2009)
World J Pediatr
, vol.5
, pp. 169-176
-
-
Benvenuto, A.1
Moavero, R.2
Alessandrelli, R.3
Manzi, B.4
Curatolo, P.5
-
3
-
-
77952091222
-
Understanding and determining the etiology of autism
-
Currenti S.A. Understanding and determining the etiology of autism. Cell Mol Neurobiol 2010, 30:161-171.
-
(2010)
Cell Mol Neurobiol
, vol.30
, pp. 161-171
-
-
Currenti, S.A.1
-
4
-
-
33846671855
-
Predictors of optimal outcome in Toddlers diagnosed with autism spectrum disorders
-
Sutera S., Pandey J., Esser E.L., Rosenthal M.A., Wilson L.B., Barton M., et al. Predictors of optimal outcome in Toddlers diagnosed with autism spectrum disorders. J Autism Dev Disord 2007, 37:98-107.
-
(2007)
J Autism Dev Disord
, vol.37
, pp. 98-107
-
-
Sutera, S.1
Pandey, J.2
Esser, E.L.3
Rosenthal, M.A.4
Wilson, L.B.5
Barton, M.6
-
5
-
-
65649129003
-
How can early, intensive training help a genetic disorder?
-
Altemeier W.A., Altemeier L.E. How can early, intensive training help a genetic disorder?. Pediatr Ann 2009, 38:167-170.
-
(2009)
Pediatr Ann
, vol.38
, pp. 167-170
-
-
Altemeier, W.A.1
Altemeier, L.E.2
-
6
-
-
84872370133
-
An Italian prospective study on autism treatment: the earlier, the better?
-
Vivanti G., Manzi B., Benvenuto A., Battan B., Curatolo P. An Italian prospective study on autism treatment: the earlier, the better?. Autism 2011, 10.4172/auo.1000102.
-
(2011)
Autism
-
-
Vivanti, G.1
Manzi, B.2
Benvenuto, A.3
Battan, B.4
Curatolo, P.5
-
7
-
-
75649107225
-
Novel and emerging treatments for autism spectrum disorders: a systematic review
-
Rossignol D.A. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry 2009, 21:213-236.
-
(2009)
Ann Clin Psychiatry
, vol.21
, pp. 213-236
-
-
Rossignol, D.A.1
-
8
-
-
2342417739
-
Pharmacologic treatment of autism
-
Palermo M.T., Curatolo P. Pharmacologic treatment of autism. J Child Neurol 2004, 19:155-164.
-
(2004)
J Child Neurol
, vol.19
, pp. 155-164
-
-
Palermo, M.T.1
Curatolo, P.2
-
9
-
-
60249083550
-
Pharmacologic treatment for the core deficits and associated symptoms of autism in children
-
West L., Waldrop J., Brunssen S. Pharmacologic treatment for the core deficits and associated symptoms of autism in children. J Pediatr Health Care 2009, 23:75-89.
-
(2009)
J Pediatr Health Care
, vol.23
, pp. 75-89
-
-
West, L.1
Waldrop, J.2
Brunssen, S.3
-
10
-
-
82755194994
-
Assessment of health-related quality of life among primary caregivers of children with autism spectrum disorders
-
Khanna R., Madhavan S.S., Smith M.J., Patrick J.H., Tworek C., Becker-Cottrill B. Assessment of health-related quality of life among primary caregivers of children with autism spectrum disorders. J Autism Dev Disord 2011, 41:1214-1227.
-
(2011)
J Autism Dev Disord
, vol.41
, pp. 1214-1227
-
-
Khanna, R.1
Madhavan, S.S.2
Smith, M.J.3
Patrick, J.H.4
Tworek, C.5
Becker-Cottrill, B.6
-
11
-
-
77955863445
-
Health-related quality of life in children with autism spectrum disorders: results from the autism treatment network
-
Kuhlthau K., Orlich F., Hall T.A., Sikora D., Kovacs E.A., Delahaye J., et al. Health-related quality of life in children with autism spectrum disorders: results from the autism treatment network. J Autism Dev Disord 2010, 40:721-729.
-
(2010)
J Autism Dev Disord
, vol.40
, pp. 721-729
-
-
Kuhlthau, K.1
Orlich, F.2
Hall, T.A.3
Sikora, D.4
Kovacs, E.A.5
Delahaye, J.6
-
12
-
-
54049103639
-
Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder
-
Hartley S.L., Sikora D.M., McCoy R. Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder. J Intellect Disabil Res 2008, 52:819-829.
-
(2008)
J Intellect Disabil Res
, vol.52
, pp. 819-829
-
-
Hartley, S.L.1
Sikora, D.M.2
McCoy, R.3
-
13
-
-
77954934909
-
Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder
-
Frazier T.W., Youngstrom E.A., Haycook T., Sinoff A., Dimitriou F., Knapp J., et al. Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder. J Child Adolesc Psychopharmacol 2010, 20:167-177.
-
(2010)
J Child Adolesc Psychopharmacol
, vol.20
, pp. 167-177
-
-
Frazier, T.W.1
Youngstrom, E.A.2
Haycook, T.3
Sinoff, A.4
Dimitriou, F.5
Knapp, J.6
-
14
-
-
83055180252
-
High prescription drug use and associated costs among medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network
-
Logan S.L., Nicholas J.S., Carpenter L.A., King L.B., Garrett-Mayer E., Charles J.M. High prescription drug use and associated costs among medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Ann Epidemiol 2012, 22:1-8.
-
(2012)
Ann Epidemiol
, vol.22
, pp. 1-8
-
-
Logan, S.L.1
Nicholas, J.S.2
Carpenter, L.A.3
King, L.B.4
Garrett-Mayer, E.5
Charles, J.M.6
-
15
-
-
79955491854
-
A systematic review of medical treatments for children with autism spectrum disorders
-
McPheeters M.L., Warren Z., Sathe N., Bruzek J.L., Krishnaswami S., Jerome R.N., et al. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 2011, 127:e1312-21.
-
(2011)
Pediatrics
, vol.127
-
-
McPheeters, M.L.1
Warren, Z.2
Sathe, N.3
Bruzek, J.L.4
Krishnaswami, S.5
Jerome, R.N.6
-
16
-
-
82055164151
-
Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010
-
Schieve L.A., Gonzalez V., Boulet S.L., Visser S.N., Rice C.E., Braun K.V., et al. Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010. Res Dev Disabil 2011, 33:467-476.
-
(2011)
Res Dev Disabil
, vol.33
, pp. 467-476
-
-
Schieve, L.A.1
Gonzalez, V.2
Boulet, S.L.3
Visser, S.N.4
Rice, C.E.5
Braun, K.V.6
-
17
-
-
77949426427
-
Epidemiology and management of insomnia in children with autistic spectrum disorders
-
Miano S., Ferri R. Epidemiology and management of insomnia in children with autistic spectrum disorders. Paediatr Drugs 2010, 12:75-84.
-
(2010)
Paediatr Drugs
, vol.12
, pp. 75-84
-
-
Miano, S.1
Ferri, R.2
-
18
-
-
79960957094
-
Melatonin in autism spectrum disorders: a systematic review and meta-analysis
-
Rossignol D.A., Frye R.E. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011, 53:783-792.
-
(2011)
Dev Med Child Neurol
, vol.53
, pp. 783-792
-
-
Rossignol, D.A.1
Frye, R.E.2
-
19
-
-
84864335819
-
Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes
-
Malow B., Adkins K.W., McGrew S.G., Wang L., Goldman S.E., Fawkes D., et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord 2011, 10.1007/s10803-011-1418-3.
-
(2011)
J Autism Dev Disord
-
-
Malow, B.1
Adkins, K.W.2
McGrew, S.G.3
Wang, L.4
Goldman, S.E.5
Fawkes, D.6
-
20
-
-
79955977714
-
Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey
-
Frye R.E., Sreenivasula S., Adams J.B. Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC Pediatr 2011, 11:37.
-
(2011)
BMC Pediatr
, vol.11
, pp. 37
-
-
Frye, R.E.1
Sreenivasula, S.2
Adams, J.B.3
-
21
-
-
79959846278
-
Aggression in children and adolescents with ASD: prevalence and risk factors
-
Kanne S.M., Mazurek M.O. Aggression in children and adolescents with ASD: prevalence and risk factors. J Autism Dev Disord 2011, 41:926-937.
-
(2011)
J Autism Dev Disord
, vol.41
, pp. 926-937
-
-
Kanne, S.M.1
Mazurek, M.O.2
-
22
-
-
39149096262
-
Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial
-
Miral S., Gencer O., Inal-Emiroglu F.N., Baykara B., Baykara A., Dirik E. Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry 2008, 17:1-8.
-
(2008)
Eur Child Adolesc Psychiatry
, vol.17
, pp. 1-8
-
-
Miral, S.1
Gencer, O.2
Inal-Emiroglu, F.N.3
Baykara, B.4
Baykara, A.5
Dirik, E.6
-
23
-
-
20044374710
-
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology
-
McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005, 162:1142-1148.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 1142-1148
-
-
McDougle, C.J.1
Scahill, L.2
Aman, M.G.3
McCracken, J.T.4
Tierney, E.5
Davies, M.6
-
24
-
-
33746053489
-
Risperidone in children with autism: randomized, placebo-controlled, double-blind study
-
Nagaraj R., Singhi P., Malhi P. Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol 2006, 21:450-455.
-
(2006)
J Child Neurol
, vol.21
, pp. 450-455
-
-
Nagaraj, R.1
Singhi, P.2
Malhi, P.3
-
25
-
-
33847221134
-
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial
-
Pandina G.J., Bossie C.A., Youssef E., Zhu Y., Dunbar J. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 2007, 37:367-373.
-
(2007)
J Autism Dev Disord
, vol.37
, pp. 367-373
-
-
Pandina, G.J.1
Bossie, C.A.2
Youssef, E.3
Zhu, Y.4
Dunbar, J.5
-
26
-
-
29944444165
-
Acute and long-term safety and tolerability of risperidone in children with autism
-
Aman M.G., Arnold L.E., McDougle C.J., Vitiello B., Scahill L., Davies M., et al. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 2005, 15:869-884.
-
(2005)
J Child Adolesc Psychopharmacol
, vol.15
, pp. 869-884
-
-
Aman, M.G.1
Arnold, L.E.2
McDougle, C.J.3
Vitiello, B.4
Scahill, L.5
Davies, M.6
-
27
-
-
33846562907
-
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism
-
Anderson G.M., Scahill L., McCracken J.T., McDougle C.J., Aman M.G., Tierney E., et al. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry 2007, 61:545-550.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 545-550
-
-
Anderson, G.M.1
Scahill, L.2
McCracken, J.T.3
McDougle, C.J.4
Aman, M.G.5
Tierney, E.6
-
28
-
-
71449095638
-
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
-
Marcus R.N., Owen R., Kamen L., Manos G., McQuade R.D., Carson W.H., et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009, 48:1110-1119.
-
(2009)
J Am Acad Child Adolesc Psychiatry
, vol.48
, pp. 1110-1119
-
-
Marcus, R.N.1
Owen, R.2
Kamen, L.3
Manos, G.4
McQuade, R.D.5
Carson, W.H.6
-
29
-
-
71949121464
-
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
-
Owen R., Sikich L., Marcus R.N., Corey-Lisle P., Manos G., McQuade R.D., et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009, 124:1533-1540.
-
(2009)
Pediatrics
, vol.124
, pp. 1533-1540
-
-
Owen, R.1
Sikich, L.2
Marcus, R.N.3
Corey-Lisle, P.4
Manos, G.5
McQuade, R.D.6
-
30
-
-
79958786682
-
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study
-
Marcus R.N., Owen R., Manos G., Mankoski R., Kamen L., McQuade R.D., et al. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. J Child Adolesc Psychopharmacol 2011, 21:229-236.
-
(2011)
J Child Adolesc Psychopharmacol
, vol.21
, pp. 229-236
-
-
Marcus, R.N.1
Owen, R.2
Manos, G.3
Mankoski, R.4
Kamen, L.5
McQuade, R.D.6
-
31
-
-
79955600656
-
Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors
-
Beherec L., Lambrey S., Quilici G., Rosier A., Falissard B., Guillin O. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors. J Clin Psychopharmacol 2011, 31:341-344.
-
(2011)
J Clin Psychopharmacol
, vol.31
, pp. 341-344
-
-
Beherec, L.1
Lambrey, S.2
Quilici, G.3
Rosier, A.4
Falissard, B.5
Guillin, O.6
-
32
-
-
33750952522
-
A doubl blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder
-
Hollander E., Wasserman S., Swanson E.N., Chaplin W., Schapiro M.L., Zagursky K., et al. A doubl blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol 2006, 16:541-548.
-
(2006)
J Child Adolesc Psychopharmacol
, vol.16
, pp. 541-548
-
-
Hollander, E.1
Wasserman, S.2
Swanson, E.N.3
Chaplin, W.4
Schapiro, M.L.5
Zagursky, K.6
-
33
-
-
68949141618
-
Pharmacologic treatment of impulsive aggression with antiepileptic drugs
-
Stanford M.S., Anderson N.E., Lake S.L., Baldridge R.M. Pharmacologic treatment of impulsive aggression with antiepileptic drugs. Curr Treat Options Neurol 2009, 11:383-390.
-
(2009)
Curr Treat Options Neurol
, vol.11
, pp. 383-390
-
-
Stanford, M.S.1
Anderson, N.E.2
Lake, S.L.3
Baldridge, R.M.4
-
34
-
-
76749085678
-
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders
-
Hollander E., Chaplin W., Soorya L., Wasserman S., Novotny S., Rusoff J., et al. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology 2010, 35:990-998.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 990-998
-
-
Hollander, E.1
Chaplin, W.2
Soorya, L.3
Wasserman, S.4
Novotny, S.5
Rusoff, J.6
-
35
-
-
32844464646
-
Divalproex sodium vs placebo in the treatment of repetitive behaviours in autism spectrum disorders
-
Hollander E., Soorya L., Wasserman S., Esposito K., Chaplin W., Anagnostou E. Divalproex sodium vs placebo in the treatment of repetitive behaviours in autism spectrum disorders. Int J Neuropsychopharmacol 2006, 9:209-213.
-
(2006)
Int J Neuropsychopharmacol
, vol.9
, pp. 209-213
-
-
Hollander, E.1
Soorya, L.2
Wasserman, S.3
Esposito, K.4
Chaplin, W.5
Anagnostou, E.6
-
36
-
-
8144227746
-
A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders
-
Hardan A.Y., Jou R.J., Handen B.L. A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol 2004, 14:426-432.
-
(2004)
J Child Adolesc Psychopharmacol
, vol.14
, pp. 426-432
-
-
Hardan, A.Y.1
Jou, R.J.2
Handen, B.L.3
-
37
-
-
33749236065
-
Topiramate in children with autistic spectrum disorders
-
Mazzone L., Ruta L. Topiramate in children with autistic spectrum disorders. Brain Dev 2006, 28:668.
-
(2006)
Brain Dev
, vol.28
, pp. 668
-
-
Mazzone, L.1
Ruta, L.2
-
38
-
-
77956438227
-
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder
-
Rezaei V., Mohammadi M.R., Ghanizadeh A., Sahraian A., Tabrizi M., Rezazadeh S.A., et al. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1269-1272.
-
(2010)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.34
, pp. 1269-1272
-
-
Rezaei, V.1
Mohammadi, M.R.2
Ghanizadeh, A.3
Sahraian, A.4
Tabrizi, M.5
Rezazadeh, S.A.6
-
39
-
-
33749333337
-
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study
-
Wasserman S., Iyengar R., Chaplin W.F., Watner D., Waldoks S.E., Anagnostou E., et al. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Int Clin Psychopharmacol 2006, 21:363-367.
-
(2006)
Int Clin Psychopharmacol
, vol.21
, pp. 363-367
-
-
Wasserman, S.1
Iyengar, R.2
Chaplin, W.F.3
Watner, D.4
Waldoks, S.E.5
Anagnostou, E.6
-
40
-
-
0035321893
-
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial
-
Belsito K.M., Law P.A., Kirk K.S., Landa R.J., Zimmerman A.W. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 2001, 31:175-181.
-
(2001)
J Autism Dev Disord
, vol.31
, pp. 175-181
-
-
Belsito, K.M.1
Law, P.A.2
Kirk, K.S.3
Landa, R.J.4
Zimmerman, A.W.5
-
41
-
-
77950859884
-
Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder
-
Rommelse N.N., Franke B., Geurts H.M., Hartman C.A., Buitelaar J.K. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010, 19:281-295.
-
(2010)
Eur Child Adolesc Psychiatry
, vol.19
, pp. 281-295
-
-
Rommelse, N.N.1
Franke, B.2
Geurts, H.M.3
Hartman, C.A.4
Buitelaar, J.K.5
-
42
-
-
84555189923
-
Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder
-
Frazier T.W., Shattuck P.T., Narendorf S.C., Cooper B.P., Wagner M., Spitznagel E.L. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2011, 21:571-579.
-
(2011)
J Child Adolesc Psychopharmacol
, vol.21
, pp. 571-579
-
-
Frazier, T.W.1
Shattuck, P.T.2
Narendorf, S.C.3
Cooper, B.P.4
Wagner, M.5
Spitznagel, E.L.6
-
43
-
-
33845749041
-
Drug therapy for attention deficit/ hyperactivity disorder-like symptoms in autistic disorder
-
Hazell P. Drug therapy for attention deficit/ hyperactivity disorder-like symptoms in autistic disorder. J Paediatr Child Health 2007, 43:19-24.
-
(2007)
J Paediatr Child Health
, vol.43
, pp. 19-24
-
-
Hazell, P.1
-
44
-
-
3342976049
-
Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study
-
Di Martino A., Melis G., Cianchetti C., Zuddas A. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study. J Child Adolesc Psychopharmacol 2004, 14:207-218.
-
(2004)
J Child Adolesc Psychopharmacol
, vol.14
, pp. 207-218
-
-
Di Martino, A.1
Melis, G.2
Cianchetti, C.3
Zuddas, A.4
-
45
-
-
27744466024
-
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
-
Research Units on Pediatric Psychopharmacology Autism Network
-
Research Units on Pediatric Psychopharmacology Autism Network Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 2005, 62:1266-1274.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 1266-1274
-
-
-
46
-
-
59849097573
-
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity
-
Jahromi L., Kasari C.L., McCracken J.T., Lee L.S., Aman M.G., McDougle C.J., et al. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord 2009, 39:395-404.
-
(2009)
J Autism Dev Disord
, vol.39
, pp. 395-404
-
-
Jahromi, L.1
Kasari, C.L.2
McCracken, J.T.3
Lee, L.S.4
Aman, M.G.5
McDougle, C.J.6
-
47
-
-
33846643952
-
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures
-
Posey D.J., Aman M.G., McCracken J.T., Scahill L., Tierney E., Arnold L.E., et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 2007, 61:538-544.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 538-544
-
-
Posey, D.J.1
Aman, M.G.2
McCracken, J.T.3
Scahill, L.4
Tierney, E.5
Arnold, L.E.6
-
48
-
-
33750944897
-
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders
-
Posey D.J., Wiegand R.E., Wilkerson J., Maynard M., Stigler K.A., McDougle C.J. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol 2006, 16:599-610.
-
(2006)
J Child Adolesc Psychopharmacol
, vol.16
, pp. 599-610
-
-
Posey, D.J.1
Wiegand, R.E.2
Wilkerson, J.3
Maynard, M.4
Stigler, K.A.5
McDougle, C.J.6
-
49
-
-
82455167368
-
Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study
-
Charnsil C. Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study. J Atten Disord 2011, 15:684-689.
-
(2011)
J Atten Disord
, vol.15
, pp. 684-689
-
-
Charnsil, C.1
-
50
-
-
33749053222
-
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial
-
Arnold L.E., Aman M.G., Cook A.M., Witwer A.N., Hall K.L., Thompson S., et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 2006, 45:1196-1205.
-
(2006)
J Am Acad Child Adolesc Psychiatry
, vol.45
, pp. 1196-1205
-
-
Arnold, L.E.1
Aman, M.G.2
Cook, A.M.3
Witwer, A.N.4
Hall, K.L.5
Thompson, S.6
-
51
-
-
80051878678
-
Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder
-
Zeiner P., Gjevik E., Weidle B. Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder. Acta Paediatr 2011, 100:1258-1261.
-
(2011)
Acta Paediatr
, vol.100
, pp. 1258-1261
-
-
Zeiner, P.1
Gjevik, E.2
Weidle, B.3
-
52
-
-
33750966156
-
A prospective open trial of guanfacine in children with pervasive developmental disorders
-
Scahill L., Aman M.G., McDougle C.J., McCracken J.T., Tierney E., Dziura J., et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 2006, 16:589-598.
-
(2006)
J Child Adolesc Psychopharmacol
, vol.16
, pp. 589-598
-
-
Scahill, L.1
Aman, M.G.2
McDougle, C.J.3
McCracken, J.T.4
Tierney, E.5
Dziura, J.6
-
53
-
-
51249117402
-
Guanfacine in children with autism and/or intellectual disabilities
-
Handen B.L., Sahl R., Hardan A.Y. Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr 2008, 29:303-308.
-
(2008)
J Dev Behav Pediatr
, vol.29
, pp. 303-308
-
-
Handen, B.L.1
Sahl, R.2
Hardan, A.Y.3
-
54
-
-
77249163833
-
Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity
-
McCracken J.T., Aman M.G., McDougle C.J., Tierney E., Shiraga S., Whelan F., et al. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol 2010, 20:1-5.
-
(2010)
J Child Adolesc Psychopharmacol
, vol.20
, pp. 1-5
-
-
McCracken, J.T.1
Aman, M.G.2
McDougle, C.J.3
Tierney, E.4
Shiraga, S.5
Whelan, F.6
-
55
-
-
0026794346
-
Clonidine treatment of hyperactive and impulsive children with autistic disorder
-
Jaselskis C.A., Cook E.H., Fletcher K.E., Leventhal B.L. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 1992, 12:322-327.
-
(1992)
J Clin Psychopharmacol
, vol.12
, pp. 322-327
-
-
Jaselskis, C.A.1
Cook, E.H.2
Fletcher, K.E.3
Leventhal, B.L.4
-
56
-
-
45949091139
-
Use of clonidine in children with autism spectrum disorders
-
Ming X., Gordon E., Kang N., Wagner G.C. Use of clonidine in children with autism spectrum disorders. Brain Dev 2008, 30:454-460.
-
(2008)
Brain Dev
, vol.30
, pp. 454-460
-
-
Ming, X.1
Gordon, E.2
Kang, N.3
Wagner, G.C.4
-
57
-
-
67650915116
-
Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors
-
West L., Brunssen S.H., Waldrop J. Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. J Spec Pediatr Nurs 2009, 14:183-191.
-
(2009)
J Spec Pediatr Nurs
, vol.14
, pp. 183-191
-
-
West, L.1
Brunssen, S.H.2
Waldrop, J.3
-
59
-
-
13944264748
-
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism
-
Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., Wasserman S., et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 2005, 30:582-589.
-
(2005)
Neuropsychopharmacology
, vol.30
, pp. 582-589
-
-
Hollander, E.1
Phillips, A.2
Chaplin, W.3
Zagursky, K.4
Novotny, S.5
Wasserman, S.6
-
60
-
-
84858971972
-
A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders
-
Hollander E., Soorya L., Chaplin W., Anagnostou E., Taylor B.P., Ferretti C.J., et al. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry 2011, 10.1176/appi.ajp. 2011.10050764.
-
(2011)
Am J Psychiatry
-
-
Hollander, E.1
Soorya, L.2
Chaplin, W.3
Anagnostou, E.4
Taylor, B.P.5
Ferretti, C.J.6
-
61
-
-
66449098701
-
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism
-
King B.H., Hollander E., Sikich L., McCracken J.T., Scahill L., Bregman J.D., et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 2009, 66:583-590.
-
(2009)
Arch Gen Psychiatry
, vol.66
, pp. 583-590
-
-
King, B.H.1
Hollander, E.2
Sikich, L.3
McCracken, J.T.4
Scahill, L.5
Bregman, J.D.6
-
62
-
-
15344341046
-
An open-label trial of escitalopram in pervasive developmental disorders
-
Owley T., Walton L., Salt J., Guter S., Winnega M., Leventhal B., et al. An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 2005, 44:343-348.
-
(2005)
J Am Acad Child Adolesc Psychiatry
, vol.44
, pp. 343-348
-
-
Owley, T.1
Walton, L.2
Salt, J.3
Guter, S.4
Winnega, M.5
Leventhal, B.6
-
63
-
-
77249129027
-
A pharmacogenetic study of escitalopram in autism spectrum disorders
-
Owley T., Brune C.W., Salt J., Walton L., Guter S., Ayuyao N., et al. A pharmacogenetic study of escitalopram in autism spectrum disorders. Autism Res 2010, 3:1-7.
-
(2010)
Autism Res
, vol.3
, pp. 1-7
-
-
Owley, T.1
Brune, C.W.2
Salt, J.3
Walton, L.4
Guter, S.5
Ayuyao, N.6
-
64
-
-
84864781015
-
Evaluation of the GABAergic nervous system in autistic brain: (123) I-iomazenil SPECT study
-
Mori T., Mori K., Fujii E., Toda Y., Miyazaki M., Harada M., et al. Evaluation of the GABAergic nervous system in autistic brain: (123) I-iomazenil SPECT study. Brain Dev 2012, 34:648-654.
-
(2012)
Brain Dev
, vol.34
, pp. 648-654
-
-
Mori, T.1
Mori, K.2
Fujii, E.3
Toda, Y.4
Miyazaki, M.5
Harada, M.6
-
65
-
-
84855528326
-
Glutamate mediated signaling in the pathophysiology of autism spectrum disorders
-
Choudhury P.R., Lahiri S., Rajamma U. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 2011, 10.1016/j.pbb.2011.06.023.
-
(2011)
Pharmacol Biochem Behav
-
-
Choudhury, P.R.1
Lahiri, S.2
Rajamma, U.3
-
66
-
-
77953028667
-
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes
-
Wegiel J., Kuchna I., Nowicki K., Imaki H., Wegiel J., Marchi E., et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol 2010, 119:755-770.
-
(2010)
Acta Neuropathol
, vol.119
, pp. 755-770
-
-
Wegiel, J.1
Kuchna, I.2
Nowicki, K.3
Imaki, H.4
Wegiel, J.5
Marchi, E.6
-
67
-
-
84856092811
-
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments
-
Veenstra-Vanderweele J., Blakely R.D. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology 2012, 37:196-212.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 196-212
-
-
Veenstra-Vanderweele, J.1
Blakely, R.D.2
-
68
-
-
48449088655
-
Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets
-
Walker M.A. Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets. Expert Opin Ther Targets 2008, 12:949-967.
-
(2008)
Expert Opin Ther Targets
, vol.12
, pp. 949-967
-
-
Walker, M.A.1
-
69
-
-
33750957325
-
Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study
-
Troost P.W., Althaus M., Lahius B.E., Buitelaar J.K., Minderaa R.B., Hoekstra P.J. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study. J Child Adolesc Psychopharmacol 2006, 16:561-573.
-
(2006)
J Child Adolesc Psychopharmacol
, vol.16
, pp. 561-573
-
-
Troost, P.W.1
Althaus, M.2
Lahius, B.E.3
Buitelaar, J.K.4
Minderaa, R.B.5
Hoekstra, P.J.6
-
70
-
-
57149111476
-
Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children
-
Aman M.G., Hollway J.A., Leone S., Masty J., Lindsay R., Nash P., et al. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Res Dev Disabil 2009, 30:386-396.
-
(2009)
Res Dev Disabil
, vol.30
, pp. 386-396
-
-
Aman, M.G.1
Hollway, J.A.2
Leone, S.3
Masty, J.4
Lindsay, R.5
Nash, P.6
-
71
-
-
57749185836
-
Cognitive effects of risperidone in children with autism and irritable behavior
-
Aman M.G., Hollway J.A., McDougle C.J., Scahill L., Tierney E., McCracken J.T., et al. Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol 2008, 18:227-236.
-
(2008)
J Child Adolesc Psychopharmacol
, vol.18
, pp. 227-236
-
-
Aman, M.G.1
Hollway, J.A.2
McDougle, C.J.3
Scahill, L.4
Tierney, E.5
McCracken, J.T.6
-
72
-
-
58149349719
-
Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells
-
Quincozes-Santos A., Bobermin L.D., Kleinkauf-Rocha J., Souza D.O., Riesgo R., Gonçalves C.A., et al. Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:11-15.
-
(2009)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.33
, pp. 11-15
-
-
Quincozes-Santos, A.1
Bobermin, L.D.2
Kleinkauf-Rocha, J.3
Souza, D.O.4
Riesgo, R.5
Gonçalves, C.A.6
-
73
-
-
79956155995
-
Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress
-
Lee C.H., Park J.H., Yoo K.Y., Choi J.H., Hwang I.K., Ryu P.D., et al. Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress. Exp Neurol 2011, 229:450-459.
-
(2011)
Exp Neurol
, vol.229
, pp. 450-459
-
-
Lee, C.H.1
Park, J.H.2
Yoo, K.Y.3
Choi, J.H.4
Hwang, I.K.5
Ryu, P.D.6
-
74
-
-
78149431869
-
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
-
Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
-
(2010)
Nature
, vol.468
, pp. 263-269
-
-
Chao, H.T.1
Chen, H.2
Samaco, R.C.3
Xue, M.4
Chahrour, M.5
Yoo, J.6
-
75
-
-
33846238191
-
Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein
-
Selby L., Zhang C., Sun Q.Q. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett 2007, 412:227-232.
-
(2007)
Neurosci Lett
, vol.412
, pp. 227-232
-
-
Selby, L.1
Zhang, C.2
Sun, Q.Q.3
-
76
-
-
79651475390
-
Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
-
Ehninger D., Silva A.J. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. Trends Mol Med 2011, 17:78-87.
-
(2011)
Trends Mol Med
, vol.17
, pp. 78-87
-
-
Ehninger, D.1
Silva, A.J.2
-
77
-
-
80053583200
-
Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders
-
Rossignol E. Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast 2011, 2011:649325.
-
(2011)
Neural Plast
, vol.2011
, pp. 649325
-
-
Rossignol, E.1
-
78
-
-
77956227931
-
Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment
-
Tuchman R., Alessandri M., Cuccaro M. Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment. Brain Dev 2010, 32:719-730.
-
(2010)
Brain Dev
, vol.32
, pp. 719-730
-
-
Tuchman, R.1
Alessandri, M.2
Cuccaro, M.3
-
79
-
-
80053273580
-
Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice. Possible implications for the pharmacotherapy of autism spectrum disorders
-
Burket J.A., Herndon A.L., Winebarger E.E., Jacome L.F., Deutsch S.I. Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice. Possible implications for the pharmacotherapy of autism spectrum disorders. Brain Res Bull 2011, 86:152-158.
-
(2011)
Brain Res Bull
, vol.86
, pp. 152-158
-
-
Burket, J.A.1
Herndon, A.L.2
Winebarger, E.E.3
Jacome, L.F.4
Deutsch, S.I.5
-
80
-
-
34250731835
-
Memantine in children with autistic spectrum sisorders
-
Chez M.G., Burton Q., Dowling T., Chang M., Khanna P., Kramer C. Memantine in children with autistic spectrum sisorders. J Child Neurol 2007, 22:574-579.
-
(2007)
J Child Neurol
, vol.22
, pp. 574-579
-
-
Chez, M.G.1
Burton, Q.2
Dowling, T.3
Chang, M.4
Khanna, P.5
Kramer, C.6
-
81
-
-
14344267755
-
Double-blind, placebo-controlled study of amantidine hydrochloride in the treatment of children with autistic disorder
-
King B.H., Wright D.M., Handen B.L., Sikich L., Zimmerman A.W., McMahon W., et al. Double-blind, placebo-controlled study of amantidine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry 2001, 40:658-665.
-
(2001)
J Am Acad Child Adolesc Psychiatry
, vol.40
, pp. 658-665
-
-
King, B.H.1
Wright, D.M.2
Handen, B.L.3
Sikich, L.4
Zimmerman, A.W.5
McMahon, W.6
-
82
-
-
77954944264
-
Autism and oxytocin: new developments in translational approaches to therapeutics
-
Green J.J., Hollander E. Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics 2010, 7:250-257.
-
(2010)
Neurotherapeutics
, vol.7
, pp. 250-257
-
-
Green, J.J.1
Hollander, E.2
-
83
-
-
77949486670
-
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders
-
Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010, 67:692-694.
-
(2010)
Biol Psychiatry
, vol.67
, pp. 692-694
-
-
Guastella, A.J.1
Einfeld, S.L.2
Gray, K.M.3
Rinehart, N.J.4
Tonge, B.J.5
Lambert, T.J.6
-
84
-
-
0642273081
-
Evidence-based treatments in child and adolescent psychiatry: an inventory
-
McClellan J.M., Werry J.S. Evidence-based treatments in child and adolescent psychiatry: an inventory. J Am Acad Child Adolesc Psychiatry 2003, 42:1388-1400.
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 1388-1400
-
-
McClellan, J.M.1
Werry, J.S.2
-
85
-
-
72949098166
-
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1
-
Palmieri L., Papaleo V., Porcelli V., Scarcia P., Gaita L., Sacco R., et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 2010, 15:38-52.
-
(2010)
Mol Psychiatry
, vol.15
, pp. 38-52
-
-
Palmieri, L.1
Papaleo, V.2
Porcelli, V.3
Scarcia, P.4
Gaita, L.5
Sacco, R.6
-
86
-
-
79951614797
-
Can ziconotide as a N-type voltage-sensitive calcium channel blocker open a new mode for treatment of autism? A hypothesis
-
Ghanizadeh A. Can ziconotide as a N-type voltage-sensitive calcium channel blocker open a new mode for treatment of autism? A hypothesis. Neurosciences 2011, 16:83.
-
(2011)
Neurosciences
, vol.16
, pp. 83
-
-
Ghanizadeh, A.1
|